申请人:McNeilab, Inc.
公开号:US04595688A1
公开(公告)日:1986-06-17
Novel compounds are disclosed, which are derivatives of 1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]-isoquinolines, represented by general formula (I): ##STR1## as well as pharmaceutical compositions and methods for the treatment of depression in warm-blooded animals, e.g., man. Novel intermediates are also part of the invention.
披露了新的化合物,这些化合物是1,2,3,5,6,10b-六氢吡咯并[2,1-a]-异喹啉的衍生物,用一般式(I)表示:##STR1##以及治疗温血动物(例如人类)抑郁症的药物组合物和方法。新的中间体也是该发明的一部分。